![]() |
市場調查報告書
商品編碼
2128596
真空治療設備市場規模、佔有率、成長率、全球產業分析、區域趨勢及2026-2034年預測。Vacuum Therapy Device Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球真空治療設備市場預計到2025年將達到25.6億美元,並從2026年的27.4億美元成長到2034年的44.7億美元,預測期內複合年成長率(CAGR)為6.3%。北美地區引領全球市場,預計到2025年將佔44.92%的市場佔有率,這主要得益於其先進的醫療基礎設施、慢性傷口病例的增加以及創新創傷護理技術的普及。
真空療法設備是一種非侵入性系統,主要用於治療急慢性傷口以及勃起功能障礙(ED)。這些設備透過對傷口施加可控的負壓來促進癒合,或透過改善血液循環來治療ED。醫療保健成本不斷上漲、人口老化以及慢性病盛行率的增加正在推動全球對真空療法的需求。
市場趨勢
促進產品普及的技術進步
製造商正不斷推出攜帶式、一次性且技術先進的真空治療設備,以提高患者的舒適度和治療效率。諸如家用創傷護理系統、自動傷口沖洗技術和攜帶式負壓傷口治療(NPWT)設備等創新技術,正在將治療範圍從醫院擴展到居家照護環境。
波士頓科學公司推出的「TENACIO幫浦」等先進產品,顯示人們越來越重視創新,從而改善患者的活動能力並提高治療效果。
市場促進因素
慢性傷口盛行率的上升正在推動市場成長。
糖尿病足潰瘍、靜脈性腿部潰瘍、壓瘡和其他慢性傷口的發生率不斷上升,是推動市場需求的主要因素。負壓傷口治療已被證明是治療和促進複雜傷口癒合的有效方法。
醫療保健服務的可及性提高、老年人口的成長、居家醫療服務的擴展以及醫療專業人員意識的增強,都進一步推動了這種療法的普及。此外,領先企業持續加大研發投入,以開發創新的傷口管理解決方案。
市場限制因素
高昂的產品成本阻礙了其廣泛應用。
儘管負壓傷口治療(NPWT)設備具有顯著的臨床療效,但其價格仍然相對較高。 NPWT系統需要幫浦、敷料、儲液罐、配件以及持續的維護,這給醫院和門診診所帶來了相當大的經濟負擔。
一些國家有限的保險報銷支援和複雜的核准程序也構成了就醫障礙。這些挑戰在醫療預算仍然緊張的開發中國家市場尤為突出。
市場機遇
門診手術中心的擴建將創造新的需求。
全球門診手術中心(ASC)的數量正在增加,創造了巨大的發展機會。隨著門診手術中心越來越注重高效的患者照護、更快的復健和更少的併發症,先進的傷口管理技術的重要性也日益凸顯。
印度、中國和墨西哥等國不斷增加醫療保健投入,進一步推動了吸痰療法的普及。隨著全球手術數量的增加,預計未來幾年對吸痰療法設備的需求將進一步成長。
市場挑戰
開發中國家獲得先進醫療保健服務的限制
一些新興經濟體仍面臨醫療保健成本限制、醫療保健基礎設施不足、手術量低以及訓練有素的醫療保健專業人員短缺等挑戰。
此外,監管障礙和對先進創傷護理技術的認知度低阻礙了這些技術在發展中地區的普及和市場滲透。
依產品類型
市場區隔按以下步驟進行:
到2025年,由於慢性傷口和急性傷口的盛行率不斷上升,負壓傷口治療(NPWT)設備細分市場主導市場。持續的產品創新和不斷擴大的臨床應用預計將進一步推動該細分市場的成長。
隨著全球對非侵入性勃起功能障礙治療的認知不斷提高,預計 VED 市場將穩步成長。
用途別
市場分類如下:
預計到2025年,慢性傷口市場將佔最大的市場佔有率,達到58.8%,這主要得益於糖尿病潰瘍、壓瘡和難治性傷口發生率的上升。急性傷口市場預計在整個預測期內也將保持強勁成長。
最終用戶
市場包括:
到2025年,醫院和門診手術中心(ASC)將佔最大的市場佔有率,這主要得益於手術量增加以及需要高級創傷護理管理的患者住院人數的成長。預計在整個預測期內,該細分市場將保持其主導地位。
區域分析
北美洲
預計到2025年,北美市場規模將維持在11.5億美元,持續維持全球最大區域市場的地位。完善的醫療保健基礎設施、高額的醫療費用支出以及慢性傷口盛行率的上升,將繼續支持該地區的成長。
預計到 2026 年,美國市場規模將達到約 11 億美元,成為全球最大的國內市場。
歐洲
預計到 2026 年,歐洲市場規模將達到 6.7 億美元。技術先進的創傷護理產品日益普及以及有利的醫療保健政策正在推動該地區市場的成長。
德國和英國仍然是歐洲市場成長的主要驅動力之一。
亞太地區
預計到2026年,亞太地區的市場規模將達到6.1億美元,仍將是成長最快的地區之一。推動市場需求成長的因素包括外科手術數量的增加、醫療基礎設施的擴大以及人們對慢性傷口管理意識的提高。
由於醫療保健領域的投資增加以及患者獲得先進醫療設備的機會改善,中國和印度正在成為重要的成長市場。
拉丁美洲、中東和非洲
預計這些地區在預測期內將保持溫和成長。醫療服務可近性的提高、醫療旅遊的興起以及醫療基礎設施投資的增加,都促進了市場的發展。
近期,Solventum 收購 Acera Surgical 以及 Smith+Nephew 不斷擴大 NPWT 解決方案等發展趨勢凸顯了該行業致力於加強產品系列和擴大市場佔有率的決心。
The global vacuum therapy device market was valued at USD 2.56 billion in 2025 and is projected to grow from USD 2.74 billion in 2026 to USD 4.47 billion by 2034, registering a CAGR of 6.3% during the forecast period. North America dominated the global market with a 44.92% market share in 2025, supported by advanced healthcare infrastructure, growing chronic wound cases, and increasing adoption of innovative wound care technologies.
Vacuum therapy devices are non-invasive systems used primarily for the treatment of chronic and acute wounds and erectile dysfunction (ED). These devices improve healing outcomes by applying controlled negative pressure to wounds or improving blood flow in ED treatment. Rising healthcare expenditure, an expanding geriatric population, and increasing prevalence of chronic diseases are driving demand worldwide.
Market Trends
Technological Advancements Driving Product Adoption
Manufacturers are increasingly introducing portable, single-use, and technologically advanced vacuum therapy devices that improve patient comfort and treatment efficiency. Innovations such as home-based wound care systems, automated wound cleansing technologies, and portable negative pressure wound therapy (NPWT) devices are expanding treatment possibilities beyond hospitals into homecare settings.
The launch of advanced products such as Boston Scientific's TENACIO Pump demonstrates the growing focus on innovation, enhancing patient mobility and improving treatment outcomes.
Market Drivers
Rising Prevalence of Chronic Wounds Supporting Market Growth
The increasing incidence of diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other chronic wounds is a major factor driving market demand. Negative pressure wound therapy has become an effective treatment option for managing complex wounds and accelerating healing.
Growing healthcare accessibility, rising numbers of elderly patients, expanding home healthcare services, and increasing awareness among healthcare professionals are further supporting adoption. Additionally, leading companies continue to invest heavily in research and development to introduce innovative wound management solutions.
Market Restraints
High Product Costs Limiting Wider Adoption
Despite strong clinical benefits, vacuum therapy devices remain relatively expensive. NPWT systems require pumps, dressings, canisters, accessories, and ongoing maintenance, creating significant cost burdens for hospitals and outpatient centers.
Limited reimbursement support in certain countries and complex approval procedures also reduce accessibility. These challenges are particularly significant in developing markets where healthcare budgets remain constrained.
Market Opportunities
Expansion of Ambulatory Surgical Centers Creating New Demand
The increasing number of ambulatory surgical centers (ASCs) worldwide is creating substantial growth opportunities. ASCs focus on efficient patient care, faster recovery, and reduced complications, making advanced wound management technologies increasingly important.
Growing healthcare investments in countries such as India, China, and Mexico are further encouraging adoption. The expanding surgical procedure volume globally is expected to strengthen demand for vacuum therapy devices over the coming years.
Market Challenges
Limited Access to Advanced Healthcare in Developing Nations
Several emerging economies continue to face challenges such as limited healthcare spending, inadequate medical infrastructure, lower surgical procedure volumes, and shortages of trained healthcare professionals.
Regulatory barriers and limited awareness regarding advanced wound care technologies also hinder adoption, restricting market penetration in developing regions.
By Product Type
The market is segmented into:
The NPWT devices segment dominated the market in 2025 due to the increasing prevalence of chronic and acute wounds. Continuous product innovations and wider clinical acceptance continue to strengthen segment growth.
The VED segment is expected to witness steady growth as awareness regarding non-invasive erectile dysfunction treatment increases globally.
By Application
The market is categorized into:
The chronic wounds segment held the largest market share of 58.8% in 2025, driven by growing incidences of diabetic ulcers, pressure injuries, and non-healing wounds. The acute wounds segment is also expected to witness healthy growth throughout the forecast period.
By End User
The market includes:
Hospitals & ASCs accounted for the largest market share in 2025 due to increasing surgical procedures and rising patient admissions requiring advanced wound care management. The segment is expected to maintain its leadership position throughout the forecast period.
Regional Analysis
North America
North America remained the largest regional market with a value of USD 1.15 billion in 2025. Strong healthcare infrastructure, high healthcare expenditure, and growing prevalence of chronic wounds continue to support regional growth.
The U.S. market is expected to reach approximately USD 1.10 billion in 2026, making it the largest national market globally.
Europe
Europe is projected to achieve USD 0.67 billion by 2026. Increasing adoption of technologically advanced wound care products and favorable healthcare policies are supporting regional expansion.
Germany and the U.K. remain among the leading contributors to European market growth.
Asia Pacific
Asia Pacific is expected to reach USD 0.61 billion in 2026 and remains one of the fastest-growing regions. Rising surgical procedures, expanding healthcare infrastructure, and increasing awareness regarding chronic wound management are driving demand.
China and India are emerging as important growth markets due to growing healthcare investments and improving patient access to advanced medical devices.
Latin America and Middle East & Africa
These regions are expected to experience moderate growth during the forecast period. Improving healthcare access, increasing medical tourism, and rising investments in healthcare infrastructure are contributing to market development.
Competitive Landscape
The global vacuum therapy device market is highly competitive, with major players focusing on product innovation, acquisitions, partnerships, and portfolio expansion.
Key companies operating in the market include:
Recent developments such as Solventum's acquisition of Acera Surgical and Smith+Nephew's continued expansion of NPWT solutions highlight the industry's focus on strengthening product portfolios and expanding market presence.
Conclusion
The global vacuum therapy device market is poised for steady growth, increasing from USD 2.56 billion in 2025 to USD 4.47 billion by 2034, driven by rising chronic wound prevalence, growing adoption of negative pressure wound therapy, technological advancements, and expanding healthcare infrastructure. While high treatment costs and limited healthcare access in developing nations remain challenges, increasing investments in wound care technologies, growth in ambulatory surgical centers, and continuous product innovation are expected to create significant opportunities for market participants throughout the forecast period.
Segmentation By Product Type, Application, End User, and Region
By Product Type * Negative Pressure Wound Therapy (NPWT) Devices
By Application * Chronic Wounds
By End User * Hospitals & ASCs
By Region * North America (By Product Type, By Application, By End User, and By Country)